Mark Bloch
Impact in
- Virology top 2%
- HIV Research and Treatment
- Emergency Medicine top 1%
- HIV-related health complications and treatments
Papers in
-
- HIV/AIDS drug development and treatment 11
- HIV/AIDS Research and Interventions 7
-
- HIV-related health complications and treatments 11
- Co-authors
- Janaki Amin (5 shared papers)Andrew Carr (5 shared papers)Sean Emery (4 shared papers)Allison Martin (3 shared papers)Alexander So (6 shared papers)Thomas Bardin (6 shared papers)Gerhard Krammer (4 shared papers)Naomi Schlesinger (6 shared papers)
- Journals
- Annals of the Rheumatic Diseases (5 papers)HIV Medicine (4 papers)AIDS (3 papers)Clinical Infectious Diseases (2 papers)Lara D. Veeken (2 papers)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Mark Bloch
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 87
- Virology 391
- Emergency Medicine 481
- Hepatology 306
- Infectious Diseases 669
- Nephrology 192
Countries citing papers authored by Mark Bloch
This map shows the geographic impact of Mark Bloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bloch more than expected).
Fields of papers citing papers by Mark Bloch
This network shows the impact of papers produced by Mark Bloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bloch. The network helps show where Mark Bloch may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bloch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 250 | |
| 2 | 2015 | 218 | |
| 3 | 2004 | 208 | |
| 4 | 2009 | 176 | |
| 5 | 2000 | 83 | |
| 6 | 2001 | 64 | |
| 7 | 2014 | 53 | |
| 8 | 2010 | 43 | |
| 9 | 2019 | 43 | |
| 10 | 2005 | 42 | |
| 11 | 1973 | 36 | |
| 12 | 2007 | 35 | |
| 13 | 2012 | 31 | |
| 14 | 1972 | 31 | |
| 15 | 2010 | 21 | |
| 16 | 2008 | 17 | |
| 17 | Comparative study of lymph node cytology by puncture and histopathology. | 1967 | 17 |
| 18 | 2020 | 16 | |
| 19 | 2011 | 14 | |
| 20 | 1974 | 14 |
About Mark Bloch
Mark Bloch is a scholar working on Infectious Diseases, Emergency Medicine, Epidemiology, Rheumatology and Hepatology, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (11 papers), HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (7 papers), Hepatitis C virus research (7 papers), Gout, Hyperuricemia, Uric Acid (6 papers), Urticaria and Related Conditions (4 papers) and Drug-Induced Adverse Reactions (4 papers). The work is most often cited by research in Virology (391 citations), Emergency Medicine (481 citations), Hepatology (306 citations), Infectious Diseases (669 citations) and Nephrology (192 citations). Mark Bloch has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Janaki Amin, Andrew Carr, Sean Emery, Allison Martin, Alexander So, Thomas Bardin, Gerhard Krammer, Naomi Schlesinger, Rieke Alten and Dominik Richard. Their work appears in journals such as Annals of the Rheumatic Diseases, HIV Medicine, AIDS, Clinical Infectious Diseases and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.